Biological

Fibroblast clinical trials

studies test it: 4
open now: 0
in phase 3: 0
first study started: 2008

How each study uses Fibroblast is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Approvals

The first approval found in each region, with its record

United States: Not in FDA's approval records
European Union: Not in EMA's list of EU-wide authorisations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Fibroblast: 2

Studies by the year they started

4 studies that test it; most in 2017 (2)

Studies that test Fibroblast, by start year
Year	Studies
2008	1
2017	2
2020	1

By phase

A phase 1/2 study counts in both.

Phase 1: 2
Phase 2: 3
No phase: 1

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Burns: 1
Airway Remodeling: 1

Who runs them

Industry 0 · Other 4

Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus (1) · Royan Institute (1) · SCARM Institute, Tabriz, Iran (1) · Lithuanian University of Health Sciences (1)

Often tested with

Tested in the same studies.

Keratinocyte (1) · Eosinophil (1)

Studies

Open first, then newest update. How each study uses Fibroblast is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.